Literature DB >> 2091940

Epidemiological and clinical aspects of mycoses in patients with AIDS-related pathologies.

G Morace1, E Tamburrini, S Manzara, A Antinori, G Maiuro, G Dettori.   

Abstract

Mycological, cultural and/or serological studies were performed on 98 patients hospitalized in the Department of Infectious Diseases of the Catholic University in Rome with diagnoses of acquired immune deficiency syndrome (AIDS) or AIDS-related complex (ARC) diseases. The incidence of mycoses was evaluated by retrospectively analyzing the results of mycological examinations and comparing them with clinical manifestations. The presence of concomitant bacterial, viral and parasitic infections was also examined. For epidemiological purposes, the study was extended to include the biotyping of all yeasts isolated from patients hospitalized between September 1988 and February 1989 in the same Department. Antimycotic susceptibility was also determined for the first yeast isolate obtained from each of these patients. Oral candidiasis (50 cases) caused by Candida albicans was the most frequent mycosis, followed by esophageal candidiasis (13 cases) and cryptococcosis (6 cases). Four out of the 6 cryptococcosis patients had meningeal involvement. Systemic candidiasis (2 cases) and aspergillosis (1 case) were less common. Biotyping of yeasts isolated between September 1988 and February 1989 with the killer system revealed type 377 to be the most common among the C. albicans isolates. It represented 70% of all the yeasts isolated.

Entities:  

Mesh:

Year:  1990        PMID: 2091940     DOI: 10.1007/BF00151714

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  12 in total

Review 1.  Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies.

Authors:  L Polonelli; S Conti; W Magliani; G Morace
Journal:  Mycopathologia       Date:  1989-07       Impact factor: 2.574

2.  Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases.

Authors: 
Journal:  MMWR Suppl       Date:  1987-08-14

Review 3.  Life-threatening opportunistic fungal infection in patients with the acquired immunodeficiency syndrome.

Authors:  D Armstrong
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

Review 4.  Fungal infections in patients with AIDS and AIDS-related complex.

Authors:  K Holmberg; R D Meyer
Journal:  Scand J Infect Dis       Date:  1986

5.  A microautomated dilution method for susceptibility testing with antifungal drugs.

Authors:  L Polonelli; G Morace
Journal:  Mycopathologia       Date:  1984-04-30       Impact factor: 2.574

Review 6.  Mycoses complicating AIDS.

Authors:  A Stenderup; H Schønheyder
Journal:  Microbiol Sci       Date:  1984-12

7.  Strain differentiation of pathogenic yeasts by the killer system.

Authors:  G Morace; C Archibusacci; M Sestito; L Polonelli
Journal:  Mycopathologia       Date:  1984-02-15       Impact factor: 2.574

8.  Oral candida albicans in HIV infection.

Authors:  J Torssander; L Morfeldt-Månson; G Biberfeld; A Karlsson; P O Putkonen; J Wasserman
Journal:  Scand J Infect Dis       Date:  1987

9.  Reevaluation of the yeast killer phenomenon.

Authors:  L Polonelli; G Morace
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

10.  Killer system: a simple method for differentiating Candida albicans strains.

Authors:  L Polonelli; C Archibusacci; M Sestito; G Morace
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

View more
  3 in total

1.  Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals.

Authors:  Kaaren G Vargas; Sophie Joly
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

Review 2.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 3.  Galectins as potential therapeutic targets in STIs in the female genital tract.

Authors:  Agustin L Lujan; Diego O Croci; Gabriel A Rabinovich; Maria T Damiani
Journal:  Nat Rev Urol       Date:  2022-02-01       Impact factor: 14.432

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.